An alarming concern about the expedited drug approval process has been raised by Richard Pazdur, the new head of the FDA's drug evaluation department. Pazdur's apprehension centers around the legality and rapid pace of these initiatives, adding pressure to the agency's regulatory framework.

In a promising breakthrough, researchers discovered that a specific RNA molecule could potentially reverse nerve cell damage caused by amyotrophic lateral sclerosis (ALS). This finding could lead to effective treatments for the deadly condition commonly known as Lou Gehrig's disease.

A public inquiry criticized former UK Prime Minister Boris Johnson for his handling of the COVID pandemic, which led to increased deaths due to delayed lockdown measures. Elsewhere, Australia blocked a U.S. firm's buyout

See Full Page